SEWON INTELLIGENCE’S SMART DEVICE ‘JUST ON SLEEP’ DEBUTS ON SHOPEE SINGAPORE

KUALA LUMPUR, Sept 4 (Bernama) — South Korea-based Sewon Intelligence has officially launched JUST ON SLEEP, its smart, contactless sleep monitoring device, in Singapore via Shopee, making advanced sleep wellness and safety solutions more accessible to families in the region.

“Singaporeans work hard and need quality sleep, but safety during rest is just as important. JUST ON SLEEP delivers peace of mind by combining wellness and protection in one device,” said Sewon Intelligence Chief Executive Officer, Dr Sejin Park in a statement.

Designed to go beyond traditional sleep trackers, JUST ON SLEEP offers brainwave-synchronised audio to enhance relaxation and sleep quality while providing detailed sleep pattern insights for better daily performance.

What sets the device apart is its real-time alert system. When it detects abnormalities such as irregular heartbeat, apnoea, or unusual breathing, it instantly notifies a caregiver via the mobile app, ensuring better rest and greater safety for individuals and families.

A health-tech innovator specialising in non-contact biometric monitoring, Sewon Intelligence’s mission is to integrate smart, non-invasive solutions into daily life to support both wellness and safety.

— BERNAMA

Natural Nine to Launch Feminine Cleanser in the First Half of Next Year, Targeting Overseas Consumers

HWASEONG, South Korea, Sept 2 (Bernama-BUSINESS WIRE) — Natural Nine, a Korean body care brand, announced that it will launch a feminine wash in the first half of next year, with plans to expand into overseas markets including Singapore.

Founded in 2019, Natural Nine previously developed and launched the Leoclean men’s cleanser and Leoclean Deodorant. The new product, designed for women, aims to safely care for sensitive areas while addressing common issues associated with existing products, such as rashes, itching, and strong fragrances. It also features a wash-type foam formula to reduce the hassle of drying or wiping after use.

Leveraging this technological capability, Natural Nine plans to develop the feminine cleanser for markets such as Singapore and other international regions. The product will be formulated with herbal ingredients sourced from Korea and tailored specifically for Asian skin types.

Natural Nine stated that, like their existing Leoclean products, the upcoming feminine cleanser will be formulated with ingredients rated as EWG Green.

About Natural Nine

Natural Nine, founded in 2019, is a health and lifestyle brand dedicated to developing safe and effective body care products for sensitive skin. Starting with its flagship male cleanser Leoclean, the company has been delivering trustworthy products formulated with naturally derived ingredients and minimal skin irritation. Recently, Natural Nine has been expanding its product line to include feminine cleansers and is accelerating its entry into both domestic and international markets.

View source version on businesswire.com: 
https://www.businesswire.com/news/home/20250831404426/en/

Contact

Natural Nine
CEO
Jinhwan Ryu
+82-507-1473-3691
niff@hanmail.net

Source : Natural Nine

The 25th China International Fair for Investment & Trade will be held in Xiamen, Fujian, on September 8-11

Xiamen, Fujian Province — the host city of the CIFIT — is a modern and international city with both high quality and striking visual appeal.

XIAMEN, China, Sept. 2, 2025 /Xinhua-AsiaNet/–

The 25th China International Fair for Investment & Trade (CIFIT), themed “Join Hands with China, Invest in the Future,” will be held in Xiamen, Fujian, from September 8 to 11. 

This year’s CIFIT focuses on three major sectors — “Invest in China,” “Chinese Investment,” and “International Investment.” It will feature an exhibition area of about 120,000 m 2  and host over 70 specialized investment activities and more than 100 specialized roadshows.

The “Invest in China” section comprises various events. Nearly 100 executives from the headquarters and regional branches of multinational companies in the fields of energy, chemicals, agriculture, pharmaceuticals, and intelligent manufacturing, as well as representatives from sovereign wealth funds and international investment institutions, have confirmed their attendance. Additionally, over 100 “hidden champion” enterprises from Europe and Asia will participate.

The “China Investment” section is divided into three areas: China Outbound Investment, Overseas Comprehensive Services, and Silk Road Maritime. These zones will showcase the cooperation achievements and signature projects of Chinese enterprises worldwide. The Ministry of Commerce will organize multiple chambers of commerce to release China’s Outbound Investment Activity Index for the first time. This year’s CIFIT will also host an economic and trade exchange conference between Chinese provinces and U.S. states.

To date, delegations from more than 110 countries, regions, and international organizations have registered to attend CIFIT, and 51 countries and regions will set up exhibition booths. As the guest of honor, the United Kingdom plans to send a delegation of nearly 200 representatives from governments, businesses, and associations.

As the only major national-level investment exhibition in China, CIFIT is committed to building three platforms: two-way investment promotion, authoritative information release, and investment trend discussion. Since its inception, it has facilitated the signing of more than 30,000 projects, emerging as one of the world’s most influential international investment events.

Source: The Organizing Committee of CIFIT

From Merdeka to Medical Breakthroughs: Malaysia Leading in Clinical Research for ASEAN and the World

ASEAN clinical trials among the focus during the CRM Trial Connect 2025, an international clinical trials conference by CRM

KUALA LUMPUR, Sept 2 (Bernama) — As Malaysia celebrates its National Day, the nation also reflects on its strengthened role in global clinical research under its ASEAN Chairmanship 2025. This leadership underscores Malaysia’s commitment to advancing healthcare innovation and positioning the region as a hub for research excellence.

Since the establishment of Clinical Research Malaysia (CRM) in 2012, sponsored clinical research has generated over RM1.6 billion in Gross National Income and created more than 3,000 high-skilled jobs for Malaysians. Globally, the clinical trial market was valued at approximately USD 85 billion in 2024 and is projected to grow by 6.5% annually, with nearly half of this activity now concentrated in the Asia-Pacific region, positioning Malaysia to play a greater role in the years ahead.

At the heart of this progress are the 30,000 Malaysians who have volunteered as clinical trial participants, contributing to medical breakthroughs while gaining earlier access to innovative treatments. Their commitment shows that clinical research is not only about science but about people, whose courage and hope continue to shape a healthier future for all.

From its modest beginnings conducting clinical trials more than two decades ago, Malaysia has grown into a trusted hub for advanced and complex trials. This strength was evident last year when eight of the twenty-five new oncology therapeutics launched globally had been trialled and tested in Malaysia, allowing local patients to access groundbreaking cancer treatments earlier than most parts of the world. Beyond improving patient outcomes, Malaysia’s growing role also strengthens Asian representation in global clinical trials, particularly for diseases more prevalent in this region. These achievements reflect how far the nation has come and its readiness to shape the future of clinical research.

“Malaysia’s leadership in clinical research is not just about global recognition, it’s about keeping people at the heart of these efforts,” said CRM Chief Executive Officer, Dr Akhmal Yusof. “Our focus is on improving patient care while contributing to medical breakthroughs worldwide. As ASEAN Chair, we are proud to show how working together as a region can create benefits that reach far beyond our borders.”

This National Day, Malaysia celebrates not only its unity and independence, but a trusted hub for clinical research — for the nation, for ASEAN and for the world. 

About Clinical Research Malaysia (CRM) 

Clinical Research Malaysia (CRM) is a Global Trusted Research Management Organisation established by the Ministry of Health Malaysia in 2012. The organisation is guided by the principles of Humanity, Stability and Sustainability in providing global clinical trial solutions and enabling a thriving clinical research ecosystem in the country. At its very core, CRM aims to bring clinical research that addresses the unmet needs of patients and transforms health outcomes in Malaysia. 

CRM delivers sponsored clinical trials with Speed, Reliability and Quality through operational excellence and working with stakeholders by providing end-to-end clinical research support services. Certified with both ISO 9001:2015 (Quality Management System) and ISO 37001:2016 (Anti-Bribery Management System), and being aligned to international regulations, our core values and code of conduct are ingrained throughout CRM. The strength of this organisation lies in the people of CRM as we strive in our vision to make Malaysia the preferred clinical research hub in Asia. https://clinicalresearch.my

SOURCE: Clinical Research Malaysia (CRM) 

FOR MORE INFORMATION, PLEASE CONTACT:
Name: Siti Nazatul Tokshim 
Corporate Communications Executive       
Email: siti.nazatul@clinicalresearch.my  
Tel : +6019-784 2080 / +603-7931 5566 (ext. 123)  

–BERNAMA

iHerb Marks 29 Years With Global Expansion, Biggest Sale Yet

KUALA LUMPUR, Aug 29 (Bernama) — Global wellness online retailer, iHerb is celebrating its 29th anniversary this September with its biggest month-long sales event, highlighting its transformative growth from a California startup into a trusted global retailer serving customers globally.

Throughout September, iHerb is offering 29 per cent off daily deals and weekly brand specials across beauty, vitamins and supplements, personal care, and sports nutrition.

“As we celebrate 29 years, we are reaffirming our mission to make health and wellness accessible to everyone, everywhere, while thanking our customers with savings on the trusted products they love,” said iHerb Chief Executive Officer, Emun Zabihi in a statement.

In a major move to enhance customer experience, iHerb is rolling out 14 new fully localised languages, bringing its total to 36. From Greek to Malay and Swedish, shoppers worldwide can now explore wellness in their native tongue, making the platform more inclusive and accessible than ever.

Furthermore, iHerb’s own House Brands are expanding into cutting-edge product categories, reflecting its commitment to meeting the diverse needs of customers and their families, including their pets.

California Gold Nutrition, the company’s flagship brand, unveiled a host of new products, including gut-health support, anti-ageing supplements, and even pet wellness formulas, while Idealove, its in-house beauty and skincare line, added a sunscreen and hybrid lip-cheek product to its lineup.

With a catalogue of over 50,000 products and US$2.4 billion in 2024 sales, iHerb is also spotlighting its robust affiliate programme. (US$1=RM4.20)

The iHerb Affiliate Program is offering high earnings for new partners, where they can earn 10 per cent or more commission on qualifying purchases through their links.

Supported by a global workforce of 3,000 team members, iHerb serves over 13 million global customers and offers an unbeatable selection of vitamins, minerals, supplements and other health and wellness products.

— BERNAMA